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Endoplasmic Reticulum Stress is Transmissible among Cells of the 
Central Nervous System 
Neil T. Sprenkle 
Abstract 
Improper protein folding and trafficking are common pathological events observed in 
various cell types in neurodegenerative diseases. If the protein quality control mechanisms of the 
endoplasmic reticulum (ER) fail to re-establish proteostasis, misfolded proteins accumulate within 
the lumen of the ER and perturb normal cellular processes. While low-level stimulation of the 
unfolded protein response (UPR) is considered a beneficial physiological response to transient 
protein misfolding stress, or ER stress, sustained UPR activation resulting from prolonged ER 
stress can promote neurotoxicity. The cell-autonomous mechanisms of the UPR have been 
extensively characterized in the context of neuropathology. Nevertheless, there still remain 
unanswered questions regarding the cell-extrinsic role of the UPR under normal physiology, and 
how this mechanism is compromised in diseased states. To address this, we evaluated whether 
transferring conditioned media from ER stressed astrocytes to different cell types could modulate 
their functional characteristics. Our results indicate that ER stressed astrocytes secrete a 
mediator(s) which regulates both inflammatory and ER stress responses in other astrocytes and 
neurons in vitro. Initial exposure to this stress factor(s) confers resistance against subsequent ER 
stress to neurons by engaging the adaptive signals of the neuronal UPR. However, persistent 
exposure to this unidentified mediator(s) suppresses the initial protective effect and becomes 
cytotoxic. Overall, these findings provide insight into the cell-nonautonomous influence of ER 
stress on cells of the central nervous system. Further understanding the molecular mechanisms 
underlying this mode of intercellular communication would present novel therapeutic 
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Chapter 1: Introduction 
1.1. Motivation 
Neurological diseases are a devastating public health concern with very few effective 
treatments and no known cure. Dysfunction in protein homeostasis in brain-resident astrocytes and 
microglia can promote neuronal death though cell-nonautonomous mechanisms. This project is 
working to identify novel mechanisms regarding how cellular stress responses encourage a 
neurotoxic milieu, thereby providing novel targets for therapeutic intervention. 
1.2. Background 
Innate immune activation has emerged as a prominent component in the pathology of many 
neurodegenerative diseases. Previously, the involvement of immunity in the pathogenesis of 
neurological disorders had been greatly underappreciated. However, within the last couple decades 
we have come to realize that an aberrant inflammatory program within the central nervous system 
(CNS) contributes to neuronal dysfunction [1]. While inflammation is considered a beneficial 
physiological response, as it promotes debris clearance and aids in tissue repair, sustained 
inflammatory signaling overwhelms the resolution capabilities of the CNS [2]. This, in turn, is 
thought to be fundamental to the development of harmful neuroinflammation. Brain-resident 
microglia and astrocytes are the main source of inflammation in the brain, and under pathological 
conditions these dysregulated glial cells facilitate the events that promote a neurotoxic 
microenvironment [3, 4]. Considering that neurons have a limited regenerative capacity, excessive 
neuronal loss in the CNS has dire consequences on motor and cognitive function. A wealth of data 
now supports the hypothesis that inflammation in the CNS may contribute to neurodegeneration 
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by establishing a feed-forward inflammatory loop which ultimately leads to sustained neuronal 
damage [1, 2, 5, 6]. Importantly, this likely reflects impairment of the normal mechanisms involved 
in immune responses in the brain as inflammation, glial activation and even peripheral immune 
infiltration are essential elements of normal tissue homeostasis and repair [7, 8]. 
One of the pathological hallmarks of many neurodegenerative diseases is the accumulation of 
misfolded proteins within the ER of neurons and neuroglia. In response to ER stress, cells induce 
a highly conserved cellular stress response called the unfolded protein response (UPR) in an 
attempt to maintain homeostasis [9]. The UPR program orchestrates transcriptional and 
translational changes in the cell to minimize stress, while concomitantly inducing protein quality 
control mechanisms in an attempt to reduce protein misfolding. If resolution fails, the temporally-
regulated induction of UPR-dependent inflammatory and apoptotic pathways has the potential to 
exacerbate neuroinflammation and compromise cell fidelity [10-13].  
1.3. Experimental Hypothesis 
It is known that ER stress can be ‘transmitted’ between distinct cell types and contribute to 
chronic disease pathology. For instance, ER stressed tumor cells can upregulate canonical ER 
stress responses in myeloid cells to promote tumor growth and cancer progression through the 
secretion of an unknown soluble molecule [14]. Interestingly, low-level activation of the UPR 
plays an essential role in maintaining vital biological processes against up-coming stress by 
heightening the resolution potential of the ER stress response [15, 16]. The fact that transmissible 
ER stress has been observed across different mammalian cell populations suggests that it may be 
important for conferring cellular protection to surrounding cells in response to various forms of 
organismal stress [14, 17, 18]. Under diseased states, however, this homeostatic mechanism maybe 
compromised in order to promote disease progression.  
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In this study, we hypothesize that ER stressed astrocytes are able to transmit ER stress to 
other CNS cell types, and initially confer enhanced resistance to subsequent ER stress. However, 
prolonged ER dysfunction in receiver cells would upregulate UPR-mediated inflammatory and 
apoptotic programs that would drive severe inflammatory signaling and promote cell death, 
respectively. To test this, we incubated multiple cell types with conditioned media from ER 
stressed astrocytes to determine if they secreted soluble factors that could influence ER stress 
responses. Here we show that ER stressed astrocyte conditioned media (ACM) upregulates the 
expression of proteins associated with all three branches of the UPR. Further, IL-6, CCL2 and 
CCL20 mRNA expression was significantly enhanced in resting astrocytes incubated with ER 
stressed ACM. Treatment with the chemical chaperone TUDCA partially reduced the expression 
of these inflammatory mediators, suggesting that both the inflammatory proteins secreted by ER 
stressed astrocytes and cell-nonautonomous ER stress contribute to inflammatory gene expression. 
Mild exposure to ER stressed ACM conferred stress resistance to neurons against acute 
thapsigargin (Thaps)-induced ER stress, as neurons expressed less pro-apoptotic factors and 
exhibited significantly less caspase-3 activity. Nevertheless, this protective effect was partially lost 
after prolonged exposure to Thaps. Collectively, these findings will present novel insights into the 









1. Heneka MT, Kummer MP, Latz E: Innate immune activation in neurodegenerative 
disease. Nat Rev Immunol 2014, 14(7):463-477. 
2. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH: Mechanisms underlying 
inflammation in neurodegeneration. Cell 2010, 140(6):918-934. 
3. Sofroniew MV: Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci 2015, 
16(5):249-263. 
4. Prinz M, Priller J: Microglia and brain macrophages in the molecular age: from origin 
to neuropsychiatric disease. Nat Rev Neurosci 2014, 15(5):300-312. 
5. Block ML, Hong JS: Microglia and inflammation-mediated neurodegeneration: 
multiple triggers with a common mechanism. Prog Neurobiol 2005, 76(2):77-98. 
6. Perry VH, Nicoll JA, Holmes C: Microglia in neurodegenerative disease. Nat Rev Neurol 
2010, 6(4):193-201. 
7. DiSabato DJ, Quan N, Godbout JP: Neuroinflammation: the devil is in the details. J 
Neurochem 2016, 139 Suppl 2:136-153. 
8. Lee KM, MacLean AG: New advances on glial activation in health and disease. World 
J Virol 2015, 4(2):42-55. 
9. Hetz C, Mollereau B: Disturbance of endoplasmic reticulum proteostasis in 
neurodegenerative diseases. Nat Rev Neurosci 2014, 15(4):233-249. 
10. Bellezza I, Grottelli S, Mierla AL, Cacciatore I, Fornasari E, Roscini L, Cardinali G, 
Minelli A: Neuroinflammation and endoplasmic reticulum stress are coregulated by 
cyclo(His-Pro) to prevent LPS neurotoxicity. Int J Biochem Cell Biol 2014, 51:159-169. 
11. Logsdon AF, Lucke-Wold BP, Nguyen L, Matsumoto RR, Turner RC, Rosen CL, Huber 
JD: Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like 
behavior in a rodent model of traumatic brain injury. Brain Res 2016, 1643:140-151. 
12. Deslauriers AM, Afkhami-Goli A, Paul AM, Bhat RK, Acharjee S, Ellestad KK, 
Noorbakhsh F, Michalak M, Power C: Neuroinflammation and endoplasmic reticulum 
stress are coregulated by crocin to prevent demyelination and neurodegeneration. J 
Immunol 2011, 187(9):4788-4799. 
13. Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J: ER stress in Alzheimer's 
disease: a novel neuronal trigger for inflammation and Alzheimer's pathology. J 
Neuroinflammation 2009, 6:41. 
14. Mahadevan NR, Rodvold J, Sepulveda H, Rossi S, Drew AF, Zanetti M: Transmission of 
endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells. 
Proc Natl Acad Sci U S A 2011, 108(16):6561-6566. 
15. Inagi R, Kumagai T, Nishi H, Kawakami T, Miyata T, Fujita T, Nangaku M: 
Preconditioning with endoplasmic reticulum stress ameliorates 
mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2008, 19(5):915-922. 
16. Tsang KY, Chan D, Bateman JF, Cheah KSE: In vivo cellular adaptation to ER stress: 
survival strategies with double-edged consequences. J Cell Sci 2010, 123(Pt 13):2145-
2154. 
17. Zanetti M, Rodvold JJ, Mahadevan NR: The evolving paradigm of cell-nonautonomous 
UPR-based regulation of immunity by cancer cells. Oncogene 2016, 35(3):269-278. 
5 
 
18. Zhang H, Yue Y, Sun T, Wu X, Xiong S: Transmissible endoplasmic reticulum stress 
from myocardiocytes to macrophages is pivotal for the pathogenesis of CVB3-induced 




Chapter 2: Literature Review 
2.1. The Physiological Role of the UPR 
The majority of proteins destined for the secretory pathway present a hydrophobic N-
terminal signal sequence during the initial stages of translation [1, 2]. This amino acid sequence is 
recognized by the cytosolic protein signal-recognition particle, which coordinates cotranslational 
translocation of the nascent polypeptide across the ER membrane and into the ER lumen [3, 4]. 
Here, the unique environment of the ER lumen facilitates the proper folding events that create a 
stable protein with functional capabilities.  
The ER serves as the cell’s largest calcium store owing to the consistent active transport of 
calcium into the lumen [5]. Intraluminal ER calcium is necessary for the activation of calcium-
dependent molecular chaperones, including the ER resident glucose-regulated proteins (GRPs), 
which go on to stabilize protein folding intermediates [6]. Furthermore, the ER lumen possesses 
an oxidative environment which allow protein disulphide isomerases (PDIs) to catalyze the 
formation of disulfide bonds. Reduced PDIs are reoxidized by endoplasmic reticulum 
oxidoreductase α (Ero1α) to allow for continuous oxidation of free cysteine residues residing on 
unfolded proteins [7]. Additional post-translational modifications, such as glycosylation, are 
executed within the ER to produce a mature protein that is packaged into coat protein complex II-
coated vesicles and exported out of the ER [8, 9]. ER-derived vesicles then enter the canonical 
secretory pathway where cargo is either targeted to the plasma membrane or to other cellular 
compartments. 
Features of pathophysiological stress in the form of gene mutations, protein aggregates, 
inflammatory signals, metabolic alterations, pathogen-associated molecular patterns (PAMPs), 
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danger-associated molecular pattern molecules (DAMPs) and/or reactive oxygen or nitrogen 
species (ROS/RNS) disrupts efficient protein folding processes in the ER lumen, thus creating an 
imbalance between the protein load and the folding capabilities of the ER [10]. The UPR responds 
to cellular stress by triggering effector mechanisms that can be grouped as adaptive, alarming or 
pro-apoptotic [6]. In the adaptive phase of the UPR, mammalian cells are able to tolerate moderate 
protein misfolding by upregulating the expression of chaperone proteins to correctly fold and 
stabilize the increasing amount of polypeptide transported into the ER lumen. In an effort to 
maintain quality control, the cell also employs ER-associated degradation (ERAD) and attenuates 
translation of global messenger RNA (mRNA) to alleviate the protein load within the lumen [11, 
12]. In more severe situations, the protein folding capacity of the ER fails to keep pace with the 
increasing influx of polypeptide, as the extensive accumulation of misfolded proteins in the ER 
lumen begins to overwhelm the compensatory mechanisms of the UPR. If improperly regulated, 
the buildup of misfolded proteins will compromise normal cellular processes. Under these 
conditions, the cell initiates signaling pathways associated with cellular stress, most notably the 
activation of inflammatory pathways, and ‘alarms’ the extracellular environment of the distress so 
that the appropriate tissue-wide response is initiated [6]. If all else fails the UPR will trigger cell 
death through both caspase-dependent and -independent means [13-15]. 
Signal Transducers of the ER Stress Response 
In mammalian cells, the central proteins involved in initiating this evolutionarily conserved 
response are activating transcription factor 6 (ATF6), inositol-requiring 1α (IRE-1α) and double-
stranded RNA dependent protein kinase-like ER kinase (PERK) [10]. GRP78 (also known as 
binding immunoglobulin protein (BiP)) primarily regulates the initiation of the UPR through its 
direct interactions with each signal transducing sensor [16-18] (Figure 1). Physical contact 
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between GRP78 and the luminal domain of the ER-transmembrane proteins stabilizes their 
inactive state. High demand for chaperone-mediated protein stabilization brought on by increases 
in protein synthesis or defective protein folding recruits GRP78 away from these proteins [17]. 
Disrupting this interaction frees the luminal domain of the ER sensors, consequently inducing their 
functional conformation. Recent evidence has suggested an additional regulatory mechanism by 
which the sensors become catalytically active. By crystallizing the yeast IRE-1, Credle et al. 
elucidated a distinct peptide-binding groove in the IRE-1 luminal domain [19, 20]. In this model, 
unfolded polypeptide within the ER lumen may act as a substrate for the peptide-binding groove 
located in IRE-1. Because of the shared structural homology with that of IRE-1, PERK may also 
be activated in a similar manner [19]. These findings represent a unique sensing mechanism that 
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regulates the activation of the UPR. 
 
Interplay between active ATF6, IRE-1α and PERK initiate signaling cascades that regulate 
the transcriptional and translational landscape of the cell to selectively promote the expression 
UPR-target genes. Each of these mediators promote distinct signaling pathways which converge 
to produce an effective response to mitigate damage. If overwhelmed, these signaling proteins will 
initiate apoptosis [21] (Figure 2).  
 
Figure 1.  The Adaptive Signals of the Mammalian UPR.  The activation of PERK, IRE-1α and ATF6 
in response to protein misfolding stress primarily requires the dissociation of the molecular chaperone 
GRP78 from each of the ER stress sensors.  This initiates signaling cascades which orchestrate the 
transcriptional and translational landscape of the cell in an effort to maintain homeostasis. 
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Mammalian ATF6 is a type II transmembrane protein embedded within the ER membrane 
[22]. The carboxyl terminus of ATF6 acts as the intraluminal sensor while the amino terminus 
protrudes into the cytosol and functions as a basic leucine zipper (bZIP) transcription factor [23]. 
Dissociation of GRP78 from the luminal domain causes ATF6 to translocate to the Golgi 
apparatus. Located at the Golgi are site-1 and site-2 proteases, both of which have been implicated 
in the regulation of cholesterol metabolism [24]. It is here that ATF6 is cleaved, resulting in the 
release of the bZIP transcription factor into the cytosol [22]. From the cytosol, the processed ATF6 
fragment localizes into the nucleus and helps upregulate the expression of genes responsible for 
mediating protein folding and ERAD [22, 25].  
IRE-1α is a type 1 transmembrane protein containing an ER-sensing amino terminus, and 
a cytosolic carboxyl terminal endoribonuclease (RNase) and serine-threonine kinase domain [26, 
27]. Detection of unfolded proteins causes IRE-1α to dimerize and/or form higher order oligomers, 
which in turn activates its kinase domain. Subsequent trans-autophosphorylation stimulates the 
RNase activity of IRE-1α [28]. Acquisition of RNase catalytic activity enables for the excision of 
a 26-nucleotide intron within a mature X-box-binding protein 1 (XBP1) mRNA transcript in the 
cytosol [29]. The spliced XBP1 (sXBP1) mRNA encodes for an XBP1 isoform which, like ATF6, 
binds upstream cis-elements associated with chaperone and ERAD-mediated genes [25, 30]. 
Sustained ER stress augments the RNase activity of IRE-1α, thereby causing decreased specificity 
for XBP1 mRNA and elevated degradation of specific classes of mRNAs, 28S ribosomal RNA 
and microRNAs through regulated IRE1-dependent decay (RIDD) [31]. The degradation of RNA 
transcripts destined for the ER and ribosomal RNA is thought to initially help diminish mRNA 
translation to alleviate the protein load on the ER [32]. Nevertheless, prolonged RIDD activity 
resulting from chronic ER stress contributes to cell death by degrading ER-targeted mRNA that 
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encode proteins involved in protein folding and anti-apoptotic microRNA, thus pushing cell fate 
toward apoptosis [33-35]. 
Lastly, PERK possesses type 1 transmembrane topology and a cytosolic kinase domain 
[17]. Structural analysis has revealed that the sensing luminal domain of PERK shares a conserved 
protein sequence with that of IRE-1α [12]. Unsurprisingly, both PERK and IRE-1α respond to ER 
stress in a similar manner. Along with IRE-1α, PERK indirectly reduces the quantity of unfolded 
polypeptide within the ER to allow for more efficient chaperone-mediated protein folding in a 
well-saturated ER lumen. The dimerization of PERK leads to the activation of its cytosolic kinases, 
which subsequently phosphorylate serine 51 on the α-subunit of eukaryotic initiation factor 2α 
(eIF2α) [12]. Phosphorylation of eIF2α prevents the translation of many nuclear-encoded mRNA 
transcripts by compromising the formation of the GTP·eIF2α·Met-tRNAi ternary complex, which 
in turn prevents the assembly of the pre-initiation complex at the 5’ end of mRNA [36, 37]. 
Delaying translation re-initiation in this manner increases the probability that ribosomes will scan 
past inhibitory upstream open reading frames, resulting in increased translation of a specific subset 
of mRNAs, most notably mRNA that encodes ATF4 [36, 38]. Like ATF6, ATF4 is a bZIP 
transcription factor important for maintaining intracellular homeostasis through the upregulation 
of UPR-target genes involved in efficient protein folding, the antioxidant response and amino acid 
biosynthesis and transport [39]. In addition to promoting an adaptive response, ATF4 regulates the 
transcription of the gene encoding pro-apoptotic factor CCAAT-enhancer-binding protein 
homologous protein (CHOP) [40].  
While the role of CHOP in stress-induced apoptosis remains obscure, it is thought that 
CHOP promotes apoptosis by 1) downregulating the expression of Bcl-2, a pro-survival proto-
oncogene, 2) elevating the expression of pro-apoptotic BH3-only Bcl-2 family proteins such as 
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Bad, Bim and p53 upregulated modulator of apoptosis and 3) coordinating intracellular calcium 
signaling [40, 41]. The latter relies on the involvement of the ER. In addition to its role in mediating 
stable protein folding, the ER serves an important function in cell signaling due to its ability to 
release calcium in response to second messengers. During unremitting PERK activation, CHOP 
accumulates to a point necessary to activate Ero1α, which drives the aperture of the ER calcium 
release channel inositol 1, 4, 5-triphosphate (IP3) receptor 1 [42, 43]. Prolonged efflux of calcium 
from the ER promotes the activation of calcium/calmodulin-dependent protein kinase II, which 
plays a role in promoting cell death [43]. Moreover, free cytosolic calcium leaks into the 
mitochondrial matrix, causing mitochondrial depolarization [44]. Mitochondrial uptake of calcium 
released from the ER also elevates the production of ROS through various mechanisms, including 
activating the mitochondrial permeability transition and stimulating Krebs cycle dehydrogenases 
[39, 44, 45]. Besides facilitating calcium release, Ero1α contributes to the production of hydrogen 
peroxide within the ER lumen [46]. 
Along with targeting Bcl-2 family genes and Ero1α, CHOP binds to promoter elements 
associated with growth arrest and DNA damage-inducible protein 34 (GADD34). The induction 
of GADD34 is imperative for attenuating signals downstream of the PERK-eIF2α-ATF4 pathway. 
This GADD34-dependent negative feedback loop relies on GADD34 recruiting protein 
phosphatase 1 (PP1) to dephosphorylate eIF2α. Mutating the conserved motifs important for 
binding PP1 in GADD34 impairs eIF2α dephosphorylation, thus supporting its regulatory role in 
mediating the phosphorylation state of eIF2α [47]. Moreover, knocking out CHOP diminishes 
GADD34 protein expression, leading to elevated levels of phosphorylated eIF2α when compared 
to wild-type (WT) cells experiencing ER stress [48]. Although GADD34-mediated 
dephosphorylation of eIF2α is essential for cells to restore global mRNA translation after acute 
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insult, the overexpression of GADD34 increases the translation of mRNA transcripts induced 
during the later stages of prolonged ER stress, thereby elevating the protein load and restoring 
global translation of proteins involved in ROS production and apoptosis [49]. Additionally, 
GADD34 may have pro-apoptotic effects that are independent of its role in regulating eIF2α 
phosphorylation that contribute to ER stress-induced cell death [48, 50]. 
Another downstream effector of active PERK is the bZIP transcription factor nuclear 
factor-like 2 (Nrf-2), which is important for the expression of antioxidants [51]. Nrf-2 is normally 
sequestered within the cytosol by kelch-like ECH-associated protein 1 (Keap1) under basal states, 
however, the initiation of the UPR allows PERK to act on the Nrf-2-Keap1 complex. PERK-
mediated phosphorylation of Nrf-2 promotes its dissociation from Keap1 and translocation into 
the nucleus where it upregulates the expression of genes essential for redox homeostasis. Cullinan 
et al. demonstrated that deleting Nrf-2 compromises the ability of mouse embryonic fibroblasts 
(MEFs) to cope with ER stress, as cells without Nrf-2 were more susceptible to undergoing ER 
stress-induced apoptosis compared to WT MEFs treated with tunicamycin, a pharmacological ER 
stress-inducing agent that blocks N-linked glycosylation [52]. The same study also provided 
evidence showing that PERK phosphorylation was sufficient to disrupt the Nrf-2-Keap1 complex, 






During the UPR, PERK and ATF6 signaling have been shown to upregulate the expression 
of sXBP1 mRNA (through different mechanisms) to produce an operative transcription factor 
responsible for inducing the expression of stress-response genes [53, 54]. Furthermore, there is 
evidence that the transcription of CHOP is also under the control of the active ATF6 transcription 
factor [55]. This demonstrates that not only do the ER sensors elicit independent signaling cascades 
 
 
Figure 2.  Apoptotic Signals Associated with Chronic UPR Activation.  Persistent ER stress triggers 
the apoptotic component of the UPR.  PERK and IRE-1α drive UPR-induced apoptosis by initiating 




in the face of ER stress, but there is cross-talk between the different UPR pathways in an effort to 
provide a robust response to physiological stress. In addition to ATF6 and IRE-1α regulating the 
transcription of chaperone proteins and enzymes mediating ERAD, both have also been implicated 
in the biosynthesis of ER phospholipids, which are used to expand the ER membrane, and in the 
regulation of other aspects of cellular metabolism [56, 57]. Interestingly, components of the UPR 
play an essential role in learning, memory and behavior. The eIF2α kinases, including PERK, 
regulate memory and synaptic plasticity by modulating gene expression and translation [58]. 
Moreover, a recent study demonstrated an important role for XBP1 in facilitating memory and 
long-term potentiation through the regulation of brain-derived neurotrophic factor expression [59]. 
The involvement of the UPR in optimizing the protein folding capacity of the ER as well as 
modulating cellular metabolism and cognitive function highlights the pleiotropic actions of the ER 
stress response in maintaining tissue and organismal homeostasis. 
UPR-mediated Inflammatory Pathways 
 In addition to coordinating the expression of stress-response genes during ER stress, the 
UPR initiates inflammatory pathways essential for the innate immune response (Figure 3). The 
principal inflammatory signaling proteins activated during the UPR are the nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-κB) and the mitogen activated protein kinase 
(MAPK) family proteins c-Jun N-terminal kinase (JNK) and p38. It is important to note that NF-
κB and the MAPKs regulate not only inflammatory gene expression, but they also play a role in 





 The NF-κB family of proteins are made up of homo- and heterodimeric transcription 
factors composed of proteins in the NF-κB/Rel family [61]. In unstressed cells, NF-κB is 
sequestered within the cytosol through physical interaction with inhibitors of κB (IκB). Signaling 
through the canonical NF-κB pathway activates the serine kinase IκB kinase (IKK), which is 
composed of two catalytic subunits (IKKα and IKKβ) and a regulatory subunit (IKKγ). Site-
specific phosphorylation of IκB by IKK signals for its degradation through the ubiquitin-dependent 
 
Figure 3. Inflammatory Pathways Induced by the UPR. The UPR stimulates various inflammatory 
pathways to alert surrounding cells of potential danger. The transient interaction between impaired 
proteostasis and inflammation is considered a beneficial feature of the UPR. Nevertheless, sustained 
UPR-induced inflammation is considered a pathological factor in many chronic disorders, such as 
neurodegenerative diseases. Inflammatory pathways associated with the UPR include the NF-κB, 
JAK1/STAT3, NOD1/2-RIPK2 and MAPK (p38 and JNK) signaling pathways. 
17 
 
recruitment of the 26S proteasome [62]. Subsequently, free NF-κB is able to localize to the nucleus 
and bind to κB sites in gene promoters, and drive the expression of cytokines and cell survival 
proteins. NF-κB can be activated by various forms of cell stress. For example, in addition to ER 
stress, elevated levels of cytosolic calcium and oxidative stress have been shown to promote NF-
κB-mediated transcription [63, 64]. In the context of ER stress, the attenuation of global mRNA 
translation in response to eIF2α phosphorylation provides a means by which NF-κB is stimulated. 
Depressing mRNA translation decreases protein levels of IκB and NF-κB within the cytosol [65]. 
Because IκB has a shorter half-life than NF-κB, the higher proportion of NF-κB to IκB favors the 
migration of free NF-κB into the nucleus to upregulate the transcription of inflammatory genes.  
 Along with PERK, IRE-1α elicits inflammatory signaling during the ER stress response. 
After oligomerization, IRE-1α recruits the adaptor protein tumor-necrosis factor-α (TNF-α)-
receptor-associated factor 2 (TRAF2), which couples the activation of IRE-1α with different 
inflammatory pathways. The formation of the IRE-1α-TRAF2 complex mediates cross-talk 
between active IRE-1α and the NF-κB and MAPK signaling pathways. TRAF2 directly interacts 
with IKK and indirectly with JNK by activating apoptosis signal-regulating kinase 1 (ASK1), 
which then coordinates the activation of JNK [6, 66]. IRE-1α-mediated activation of IKK leads to 
the phosphorylation of IκB to promote NF-κB-dependent transcriptional regulation, while the IRE-
1α-dependent activation of JNK stimulates the bZIP transcription factor activator protein 1 (AP-
1). Thereafter, AP-1, a heterodimer composed of a differential combination of Fos, Jun, ATF and 
Maf sub-family members, binds to enhancer elements which upregulate the transcription of 
inflammatory genes [67].  
Interestingly, the IRE-1α-TRAF2 axis has been shown to stimulate the nucleotide-binding 
oligomerization domain 1 and 2 (NOD1/2)-receptor-interacting serine/threonine-protein kinase 2 
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(RIPK2) pathway, resulting in the activation of NF-κB [68]. This proposed mechanism was 
supported in an in vivo murine model of Brucella abortus infection. Brucella abortus induces ER 
stress by injecting host cells with the VceC virulence factor via its type IV secretion system. Here, 
Keestra-Gounder et al. demonstrated that the resulting ER stress-induced production of interleukin 
(IL)-6 in infected mice was dependent on TRAF2, NOD1/2 and RIPK2 interplay. These findings 
provided further evidence of dynamic interactions between innate immunity and UPR-induced 
inflammation. 
In conjunction with its involvement in initiating inflammation, IRE-1α can facilitate cell 
death through its interactions with the apoptotic proteins during ER stress [69]. IRE-1α-dependent 
activation of caspase-12 has been reported to be a dispensable contributor in the execution of ER 
stress-induced apoptosis in mice and rats [70-72]. Nevertheless, many human variants of caspase-
12 possess loss-of-function mutations that promote the synthesis of a truncated protein without 
functional activity, and thus may not be a significant contributor to ER stress-induced cell death 
in humans [72]. The IRE-1α-TRAF2-JNK pathway coordinates cell death by facilitating Bax-
dependent apoptosis and inhibiting the pro-apoptotic protein Bcl-2, while the IRE-1α-TRAF2-p38 
branch may enhance CHOP transcriptional activity [6, 73, 74]. This understanding highlights the 
importance of TRAF2 in linking the UPR to a diverse range of signaling pathways to trigger the 
appropriate physiological response.  
Recently, the interaction between PERK and Janus kinase 1 (JAK1) in the UPR was 
elucidated in astrocytes. It has been recognized that ER stress influences the JAK-signal 
transducers and activators of transcription (STAT) pathway [75, 76], however, the molecular 
mechanisms underlying its involvement in the context of neurodegeneration and how it alters the 
JAK-STAT pathway in glial cells remained to be clarified. We observed that JAK1-STAT3 
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signaling in ER stressed astrocytes was dependent on PERK [77]. Transfecting astrocytes with 
PERK small interfering RNA, followed by treatment with thapsigargin, a non-
competitive inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase used to induce ER stress, 
attenuated JAK1 and STAT3 phosphorylation. Additionally, PERK knockout MEFs incubated 
with thapsigargin expressed significantly less phosphorylated STAT3 and STAT3-dependent 
inflammatory cytokines and chemokines relative to their WT counterparts. Mass spectrometry 
revealed that JAK1 phosphorylates PERK at tyrosine 585 and 619 in vitro. While further 
investigation is needed to completely unravel how STAT3 is phosphorylated by the PERK/JAK1 
complex, these findings present a novel pathway implicating the UPR in driving 
neuroinflammation. 
Each of the three ER stress sensors serves a multifunctional role in maintaining ER protein 
homeostasis under transient ER stress. If the cell is unable to ameliorate intrinsic protein 
misfolding stress, the cell will induce apoptotic pathways to avoid continuously secreting distress 
signals to neighboring cells. The category of stimuli or environmental conditions may be an 
important determinant regarding whether the cell will trigger a coordinated cell death. One must 
also consider that certain cell types, such as highly secretory cells, must constantly maintain an 
optimal ER protein folding environment, making them more susceptible to ER stress.  
Chronic ER stress leads to the disproportionate activation of the ATF6, IRE-1α and PERK 
pathways to amplify the apoptotic component of the UPR [78]. Some experimental models respond 
to severe ER stress by attenuating ATF6 and IRE-1α signaling and augmenting PERK activation 
to allow apoptotic signals to dominate [78]. Because CHOP possesses a short half-life, chronic 
PERK activation is required to overwhelm the adaptive signals of the UPR to promote cell death 
[79, 80]. Similarly, sustained IRE-1α signaling has the potential to initiate apoptosis in other 
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situations. While various pharmacological approaches have provided invaluable insights into the 
physiologic role of the UPR, more work must be done to fully appreciate how each of the branches 
of the UPR respond to specific stimuli and how they integrate to mediate apoptotic events. 
2.2. ER Stress in Neurodegenerative Diseases 
The activation of the UPR plays an essential role in maintaining vital biological processes 
within the brain during cellular stress. In fact, moderate ER stress enhances cellular protection 
against subsequent insult by altering the transcriptome and proteome of the cell to increase the 
adaptive capacity of the ER, a response called the hormetic response [81-85]. However, prolonged 
ER stress developed in neurodegenerative diseases is believed to disrupt the protective 
mechanisms of the UPR, leading to the activation of inflammatory and apoptotic programs that 
promote neurotoxicity. In the following sections we will briefly describe the mechanisms 
underlying how ER stress is generated in neurodegenerative diseases, such as Alzheimer’s disease 
(AD), Parkinson’s disease (PD), Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis 
(MS), then address its potential contribution to the development of pathological 
neuroinflammation. In general, ER stress is a consequence of disturbances in protein-quality 
control machinery, ER Ca2+ dysregulation, protein-trafficking impairment or direct defects in UPR 
components [81]. 
Alzheimer’s Disease 
AD is a common age-dependent neurodegenerative disease that accounts for a significant 
number of reported dementia cases [86]. The pathology of AD is characterized by the formation 
of intracellular neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau and the 
extracellular parenchymal deposition of amyloid-β (Aβ) aggregates [87, 88]. The cytoplasmic 
protein tau normally serves to stabilize microtubules which form ‘tracks’ that facilitate 
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intracellular vesicle trafficking and axonal elongation and maturation. This is highlighted by the 
finding that knocking down tau leads to severe neurite growth defects in primary cerebellar 
neurons [89]. However, certain insults cause an imbalance between the activities of tau kinases 
and phosphatases that lead to the abnormal phosphorylation of tau [90]. In its hyperphosphorylated 
state, tau becomes soluble and, in turn, polymerizes to form oligomers and/or NFTs [91]. In the 
case for Aβ pathology, genetic studies have implicated mutations in Aβ precursor protein (APP) 
and in the transmembrane proteins presenilin-1 (PS1) and presenilin-2 (PS2), which act as subunits 
for the γ-secretase complex, as the predominant genetic factors contributing to the onset of familial 
AD  [92, 93]. Potentially pathological Aβ is liberated when APP is sequentially cleaved at the 
plasma membrane by β-secretase, then γ-secretase. [87]. This leads to an extracellular 
accumulation of either total Aβ or increase relative concentrations of amyloidogenic Aβ, such as 
Aβ42. Impaired clearance of Aβ has also been implicated in AD, as it creates an imbalance of its 
turnover in the brain [94]. 
Chronic ER dysfunction is highly associated with the memory and cognitive manifestations 
commonly observed in different experimental models of AD [95, 96]. To this point, Ma et al. 
elucidated that selectively abating the expression of PERK in mice possessing AD-linked 
mutations in genes encoding APP and PS1 prevented the aberrant phosphorylation of eIF2α [97]. 
This, in turn, improved synaptic plasticity and spatial memory in AD mice, consistent with the 
requirement for active protein translation in memory consolidation [98]. Interestingly, sXBP1 
overexpression ameliorates cognitive function in the 3x Tg AD mouse model [99]. The eIF2α 
kinases general control non-derepressible 2 (GCN2) [97] and double stranded RNA-dependent 
kinase (PKR) have also been implicated in memory impairment [96, 100]. Multiple studies have 
demonstrated that Aβ oligomers can activate PKR and induce ER stress by eliciting the TNF-α 
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pathway [96, 101]. Additionally, Aβ may stimulate ER Ca2+ release through ryanodine receptors 
and IP3 receptors, which triggers ER stress, neuronal apoptosis and mitochondrial fragmentation 
[102-104]. Inhibition of both GCN2 and PKR through different mechanisms significantly 
improves cognitive function in murine AD models [97, 100]. These findings suggest that 
pathophysiological conditions, not just ER stress, which lead to sustained eIF2α phosphorylation 
have the potential to aggravate the cognitive abnormalities seen in AD.  
Abnormal protein aggregates interfere with the normal processes involved in protein 
maintenance and trafficking in models of neurodegeneration. Regarding AD, soluble tau has been 
shown to cause pathological ER stress by targeting and impairing components involved in ERAD 
[105]. Paradoxically, pre-existing ER stress also promotes NFT formation. It is well known that 
Aβ oligomer-dependent ER stress responses can lead to the activation of different kinases, such as 
the serine/threonine kinase glycogen synthase kinase 3 (GSK-3) [106, 107]. This kinase (among 
others) is capable of subsequently phosphorylating specific epitopes on tau that contribute to the 
development of NFT [106, 107]. Therefore, ER stress and hyperphosphorylated tau could be 
induced by each other in a cycle to propagate AD pathology [108]. More recently, however, the 
correlation between NFT formation and AD severity had been scrutinized [109]. It seems now that 
soluble oligomers of tau and Aβ may be the primary neurotoxic agents that contribute to AD [109].  
It has been suggested that familial AD-linked PS1 mutations suppress the activation of 
IRE-1α. This predisposes cells to become more susceptible to ER stress due, in part, to decreases 
in protein chaperone synthesis as a result of reduced UPR induction [110]. A study using SK-N-
SH cells and fibroblasts expressing a PS1 mutant associated with familial AD demonstrated that 
mutant PS1 also disrupts PERK activation, potentially in a similar manner as IRE-1α, and delays 
nuclear accumulation of processed ATF6 in response to ER stress [111]. The aberrantly spliced 
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isoform of PS2 (PS2V) is also linked to AD. Similar to the PS1 mutations, this isoform increases 
the vulnerability of the cell to ER stress [112]. Alternatively, the over-expression of PS1 and PS2 
mutants in cells perturbs ER calcium homeostasis, implying another mechanism by which genetic 
mutations in the presenilin genes contribute to AD [113-115]. With this in mind, there is 
contradictory evidence indicating that neither ablation of PS1 or expression of familial AD-linked 
PS1 variants impairs the expression of GRP78 mRNA and the activation of IRE1-α [116]. Because 
of limited knowledge regarding how ER stress is generated during AD, more investigation is 
needed to fully appreciate how dysregulated UPR signaling contributes to the pathology of AD. 
Parkinson’s Disease 
PD is a chronic and progressive movement disorder characterized by the selective loss of 
dopaminergic neurons in the substantia nigra, and the presence of intraneuronal filamentous 
inclusion bodies called Lewy bodies. While the development of Lewy bodies is not a definitive 
causative factor, they are deemed to be a pathological hallmark of PD.  A post-mortem study 
showed that the percentage of Lewy body-containing dopaminergic neurons positive for caspase-
3 is significantly higher than the percentage of caspase-3–positive dopaminergic neurons without 
Lewy bodies, indicating that Lewy body-containing dopaminergic neurons are predisposed to 
undergo apoptosis [117]. A principal component of Lewy bodies in PD are the abnormal filaments 
of α-synuclein, which seem to form due to different genetic factors, such as the multiplication of 
the SCNA locus, or non-genetic factors, such as aberrant post-translational modifications [118-
120].  
Common mutations implicated in autosomal recessive PD reside within the Parkin gene, 
which encodes for an E3 ubiquitin ligase that is necessary for mitophagy [121, 122]. Studies using 
post-mortem brain samples and mouse models also suggest that Parkin can be inactivated by post-
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translational modifications, such as oxidation, nitrosylation and the addition of dopamine [121]. 
Disrupting the E3 ligase activity of Parkin or defects in PTEN-induced kinase 1, which recruits 
Parkin to the outer membrane of damaged mitochondria, is thought to play a critical role in the 
development of familial and sporadic PD, mainly through its failure to maintain mitochondrial 
fidelity [123]. Similarly, mutations within the gene that encodes leucine-rich repeat kinase 2 
(LRRK2) have been shown to promote PD [124]. LRRK2 is a widely expressed protein important 
for regulating various biological processes. Mutant LRRK2 is highly associated with the onset of 
inherited and sporadic PD, and the resulting LRRK2-mediated toxicity may be dependent on its 
kinase activity [125]. Nevertheless, the mechanisms underlying its role in the pathogenesis of PD 
are still being unraveled.  
The notion that prolonged ER stress contributes to PD pathology was first supported with 
the findings that neurons in toxin-induced models of PD highly expressed genes involved in the 
UPR [126]. It is now appreciated that α-synuclein-induced neurotoxicity may result from 
nitrosative stress, accumulation of ERAD substrates and/or defective vesicular trafficking, all of 
which can lead to ER stress [127]. To this point, under conditions of nitrosative stress, S-
nitrosylation directly inactivates PDI [128]. This inactivation impairs proper protein folding and 
hinders PDI-mediated attenuation of neuronal cell death [128]. Moreover, the concomitant 
accumulation of toxic α-synuclein oligomers in the ER further exacerbates the severity of ER 
stress, leading to deleterious UPR signaling [120, 129]. Some findings indicate that α-synuclein-
dependent ER stress is the result of blocking ER to Golgi vesicular trafficking, as preventing 
vesicle mobilization from the ER causes the accumulation of protein cargo within the ER lumen 
[130]. Targeting pathways associated with these abnormal phenotypes through pharmacological 
intervention in vitro has been shown to rescue neuronal loss observed in PD models [127].  
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Post-mortem analysis revealed that human PD patients exhibited greater phosphorylated 
PERK and eIF2α in neuromelanin containing dopaminergic neurons relative to control cases [131]. 
In the same study, phosphorylated PERK colocalized with α-synuclein within dopaminergic 
neurons derived from PD patients. PC12 cells possessing the A53T mutation in the α-synuclein 
gene, a point mutation that increases the tendency of α-synuclein to form amyloid-like fibrils, 
exhibit elevated levels of phosphorylated eIF2α, CHOP, GRP78 and active caspase-12 [132]. 
Treatment with the caspase inhibitor z-VAD or salubrinal, which prevents the de-phosphorylation 
of eIF2α, improved cell viability of A53T PC12 cells by attenuating apoptotic signaling [132]. 
Taken together, these findings suggest that pathological α-synuclein may exacerbate disease 
progression by promoting excessive or unmitigated ER stress responses.  
Stress-induced Parkin expression serves as a protective mechanism elicited by the UPR 
[133, 134]. The use of chromatin immunoprecipitation led to the discovery that ATF4 regulates 
Parkin gene expression by binding to CREB/ATF sites in the Parkin promoter [134]. The resulting 
increase in Parkin protein protects against ER stress-induced cell death in neurons by preventing 
the toxic accumulation of Parkin substrates. Moreover, the protective function of Parkin could be 
partially explained with the discovery that Parkin promotes the production of sXBP-1, which 
upregulates the transcription of pro-survival genes [135]. Recent evidence indicates that Parkin 
controls the function of PS1 and PS2, suggesting a possible link between defective Parkin and the 
pathogenesis of both AD and PD [136]. LRRK2 also helps maintain neuronal integrity against 
induced Parkinsonism by alleviating the consequences of ER stress. Yuan et al. demonstrated that 
LRRK2 saves neuroblastoma cells and C. elegans dopaminergic neurons from 6-OHDA or α-
synuclein toxicity [137]. They also demonstrated that loss of function mutations in LRRK2 
compromises the expression of GRP78, resulting in the hyperactivation of p38 and elevated 
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neuronal death. Collectively, impairment in these protective mechanisms in neurons provides an 
alternative disturbance that contributes to the progression of PD.  
Amyotrophic Lateral Sclerosis 
ALS is a progressive neurodegenerative disease characterized by the destruction of motor 
neurons, which leads to paralysis and poor patient prognosis [138]. Among cases of ALS, 10% are 
considered familial, while the remaining 90% of cases are sporadic [139].  A pathological 
hallmark of familial ALS is the formation of ubiquitinated cytoplasmic inclusions composed of 
misfolded superoxide dismutase-1 (SOD1) [140]. However, defects in the SOD1 gene only 
account for 20% of familial ALS cases, and 2% of sporadic cases [141, 142]. An accrual of 
evidence now connects mutations in genes encoding chromosome 9 open reading frame 72 
(C9orf72), transactive response DNA binding protein 43 (TDP43), and Fused in Sarcoma RNA-
binding protein (FUS) (among others) to ALS pathology [141, 143-145]. In all, a large proportion 
of genetic alterations implicated in ALS promote disease onset and progression by either 
perturbing protein quality control mechanisms, RNA integrity or cytoskeletal dynamics [141]. As 
in other mutations associated with neurodegenerative diseases, ALS-associated mutations are 
expressed ubiquitously within the CNS (neurons and surrounding neuroglia), with strong evidence 
that both cell-autonomous and -nonautonomous mechanisms contribute to the progressive loss of 
motor neurons [141]. 
 Mediators associated with the UPR are upregulated in the spinal cords of ALS patients 
and in mutant SOD1 transgenic mice [146-148]. For instance, CHOP is highly expressed in motor 
neurons, glial cells and spinal cords of mutant SOD1 transgenic mice [149]. A similar observation 
is seen in spinal cord samples of sporadic ALS patients [149]. ERAD impairment is considered a 
central mechanism by which mutant SOD1 induces ER stress in ALS. Here, mutant SOD1 protein 
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has been shown to inhibit a specific component of the retro-translocation machinery involved in 
ERAD called Derlin-1 by directly interacting with its cytoplasmic C-terminus [150]. Failure to 
export misfolded substrates from the ER in NSC34 cells leads to their accumulation within the ER 
lumen, which promotes neuronal death by eliciting the IRE-1-TRAF2-ASK1 pathway [150].  
Increased motor neuron loss and SOD1 aggregation is observed in SOD1G85R PERK+/- mice 
compared to SOD1G85R mice fully expressing PERK [151]. Interestingly, ATF4 deficiency in 
SOD1G85R mice exacerbates SOD1 aggregation, but delays disease onset and reduces the 
expression of pro-apoptotic genes [152]. XBP1-null NSC34 motor neurons expressing mutant 
SOD1 are more apt to clear mutant SOD1 aggregates [153]. Moreover, silencing XBP1 in vivo 
provides protection against disease progression in mutant SOD1 mice [153]. Taken together, there 
is contradictory evidence regarding the protective effects of the UPR in experimental models of 
ALS, suggesting that the extent to which the UPR contributes to ALS is context-dependent.  
PDI has been shown to be upregulated in SOD1G93A ALS rats and mice [154].  
Furthermore, post-mortem human brain samples exhibit greater PDI expression in comparison to 
controls, implying that PDI is induced in response to the abnormalities associated with ALS [155].  
The protective role of PDI in ALS emanates from its ability to facilitate folding of misfolded 
assemblies, thereby reducing SOD1 aggregate-mediated toxicity [155]. As seen in PD, PDI 
expressed in spinal cords of ALS patients is highly S-nitrosylated [156]. Increased RNS production 
has been reported in ALS, and the resulting nitrosative stress may impair the function of PDI 
through this post-translational modification [157].  
Aggregates composed of mutant TDP-43, FUS or C9orf72 also initiate the UPR program 
[158-160]. To this point, overexpressing ALS-associated mutant TDP-43 in Neuro2a 
neuroblastoma cells results in greater induction of CHOP, XBP1 and ATF6 [159]. Moreover, 
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mutations in FUS contribute to the formation of cytoplasmic protein inclusions that trigger ER 
stress responses in NSC34 motor neurons, and are found to co-localize with PDI in post-mortem 
spinal cord samples from ALS patients [161, 162]. Lastly, a study expressing poly(GA) repeats in 
neuronal cultures, which model ALS-associated repeat expansions in the C9orf72 gene, contribute 
to neuronal death by inducing ER stress [158]. When treated with salubrinal or the chemical 
chaperone TUDCA, these neurons are rescued from ER stress-mediated cell death, indicating that 
mutations in the C9orf72 gene contribute to neurotoxicity by promoting ER dysfunction [158]. 
Overall, these findings highlight how pathological assemblies implicated in ALS contribute to 
motor neuron loss. Even with the present understanding that SOD1-linked mutations only account 
for a relatively small proportion of ALS cases, many studies investigating the relationship between 
ER stress and ALS largely utilize animal models expressing mutant SOD1. Therefore, it will be of 
importance to further elucidate the mechanisms by which ER stress is generated in other ALS 
models in order to fully grasp how ER stress aggravates ALS pathology.  
Multiple Sclerosis  
MS is T lymphocyte-mediated autoimmune disease characterized by the spatiotemporal 
dissemination of white matter lesions within the CNS [163]. While the etiology of MS remains in 
question, it is thought to be initiated by autoreactive T lymphocytes that have breached the blood 
brain barrier (BBB) or the blood-cerebral spinal fluid-barrier and have mounted an autoimmune 
response directed toward self-CNS antigens [164]. Autoreactive B cells and innate immune cells, 
such as NK cells, have also been reported to localize to the CNS from the periphery during MS 
pathology [165]. In the early stages of MS, peripheral humoral and innate immune cells 
accumulate in the perivascular and ventricular spaces that separate the blood vessels from the 
adjacent brain tissue, reactivated by local antigen presenting cells and subsequently move into the 
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brain parenchyma to promote severe neuroinflammation [166]. These reactive immune cells 
release a plethora of inflammatory mediators, including nitric oxide, ROS and inflammatory 
cytokines, which impair neuronal function and activates CNS-resident astrocytes and microglia. 
Together, the continuous secretion of soluble inflammatory mediators promotes the development 
of a neurotoxic microenvironment that facilitates demyelination, axonal degeneration and 
oligodendrocyte and neuronal death.  
One explanation for the development of autoreactive T and B cells is that some viral 
antigens presented by major histocompatibility complex II in the periphery or the CNS share 
homology with that of myelin components. Effector lymphocytes that enter the perivascular space 
are reactivated by antigen presenting cells presenting myelin peptides that share sequence and 
structural similarities with foreign-peptides [167]. This phenomenon, molecular mimicry, is 
considered a potential mechanism by which pathogens break self-immunological tolerance and 
induce an autoimmune reaction. Pathogens sharing high degrees of peptide similarity with myelin-
derived peptides include Human Herpes virus type 6 and Epstein Barr virus [168]. The 
inflammatory milieu brought about by infiltrating innate immune cells and reactive T lymphocytes 
in the initial stages of the disease promotes further T cell polarization to the TH1 or TH17 subsets 
to amplify neuronal damage. From a genetic standpoint, single polymorphisms within specific 
candidate genes increase the susceptibility of individuals to developing MS. Such candidate genes 
may include genes located within the human leukocyte antigen (HLA) locus and immunological 
non-HLA genes involved in central tolerance, cytokine production and homeostatic proliferation 
[163].    
Real time qPCR analysis of CNS tissue from MS patients has revealed that the ER stress 
markers ATF4, GRP78 and CHOP are significantly upregulated in the white matter of MS patients 
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relative to tissue from non-MS individuals [169]. In agreement with these findings, a study 
performing detailed semiquantitative immunohistochemical and molecular analysis on multiple 
CNS cell-types in active MS lesions found that GRP78 and CHOP were highly upregulated in 
astrocytes, microglia and oligodendrocytes [170]. The elevated expression of UPR markers in MS 
lesions points toward a possible link between impaired ER proteostasis and the development of 
active lesions.  
There are multiple potential events hypothesized to induce ER stress during MS. Glutamate 
excitotoxicity is an important mechanism that contributes to autoimmune demyelination and lesion 
formation [171]. Glutamate induces the expression of GRP78, and GRP78 knockdown leads to a 
significant increase in excitotoxicity-induced apoptosis [172]. This suggests that glutamate 
excitotoxicity promotes neuronal death through an ER stress-dependent mechanism, and the 
upregulation of GRP78 helps neurons cope with the excessive amounts of glutamate. In 
accordance, GRP78 seems to be vital for maintaining cell survival during MS. Oligodendrocyte-
selective heterozygous deletion of GRP78 in mice induced with experimental autoimmune 
encephalomyelitis (EAE), an experimental model used to mimic the symptoms of MS, aggravates 
disease severity and enhances oligodendrocyte death [173].  
Hypoxia is another potential ER stress inducer that is characteristic in, though not restricted 
to, MS. Histological evidence points toward a similar hypoxic-type response in diseased tissue of 
MS patients, as the hypoxia-related antigen D-110 is strongly expressed in tissue also expressing 
high levels of CHOP [170]. Alternatively, expression of human endogenous retrovirus (HERV) 
envelop proteins may contribute to the pathology of MS by initiating neuroinflammatory and ER 
stress responses in the brain [174, 175]. For instance, the overexpression of the HERV envelope 
glycoprotein Syncytin-1 causes astrocytes to upregulate ER stress responses and the production of 
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proinflammatory mediators that promote oligodendrocyte toxicity [175]. Finally, the inflammatory 
environment in the CNS could trigger ER stress in highly myelinating cells, such as 
oligodendrocytes. Due to their high demand for lipid synthesis, mature oligodendrocytes are more 
susceptible to ER stress when exposed to high levels of proinflammatory mediators. It was 
previously demonstrated that interferon (IFN)-γ drives ER stress and cell death in 
oligodendrocytes both in vitro and in vivo [176]. In this same study, mice that were 
haploinsufficient for PERK were more susceptible to forced expression of IFN-γ, leading to 
myelination defects and oligodendrocyte death. Therefore, excessive neuroinflammation may 
induce ER stress in myelinating cells which would not only disrupt their ability to myelinate 
neuronal axons, but can also lead to cell death. 
ER Stress-linked Inflammation in Neurodegenerative Diseases 
The development of ER stress is considered an underlying factor contributing to the clinical 
manifestations linked to many neurodegenerative disorders. In addition to the diseases previously 
described, pathological processes associated with other neuropathologies, such as prion diseases 
[177-180], human immunodeficiency virus associated-neurocognitive disorders (HAND) [180, 
181] and a variety of lysosomal storage diseases [182], promote cellular and physiological 
challenges which perturb ER homeostasis. A unifying feature of all of these diseases is the 
presence of neuroinflammation [183-186]. While few studies have directly examined the 
interactions between ER stress and inflammation in the CNS, there is evidence that these processes 
are intimately linked [10, 187, 188].  
In brain tissue, microglia and astrocytes collaborate to mediate inflammation by integrating 
environmental information and carrying out an appropriate response. Microglia are CNS-resident 
phagocytic cells derived from the yolk sac. These sentinels of the CNS are the principal innate 
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immune cell in the brain and have a key role in orchestrating inflammatory responses [189-191]. 
Astrocytes are also considered important regulators of the CNS, as they assist in neuronal 
metabolism, synaptic transmission, lay down the barriers isolating the neural tissue of the brain 
and coordinate the finely-tuned events of neuroinflammation along with microglia [192]. These 
glial cells possess a diverse repertoire of innate receptors, such as scavenger receptors and pattern 
recognition receptors, which allow them to augment the expression of inflammatory cytokines and 
chemokines under metabolic stress or interaction with PAMPs or DAMPs [193, 194].  
Extracellular protein aggregates or oligomers underlie the pathology of various 
neurodegenerative disorders, and act as “danger signals” released from apoptotic or necrotic 
neurons [183]. These pathological assemblies can be recognized by innate immune receptors 
residing on neighboring glial cells [183, 195]. For example, Aβ oligomers are perceived to act as 
ligands for both the TNF-α receptor and toll-like receptor 4 [196]. Transient substrate-receptor 
interaction promotes an inflammatory response that initiates debris clearance via phagocytosis by 
microglia [183]. However, chronic exposure to these DAMPs or internalization of abnormal 
protein aggregates alters the functional properties of immunocompetent microglia and astrocytes 
to promote a reactive phenotype [183, 197]. In MS, autoreactive peripheral immune cells initiate 
an inflammatory response against myelin-derived antigen and promote neurotoxicity not only by 
compromising neuronal integrity directly, but causing astrocytes and microglia to secrete 
cytokines and other inflammatory mediators that contribute to demyelination [183, 198].  
While chronic ER stress in neurons largely triggers signals to initiate apoptosis, extensive 
ER stress in glial cells has the potential to promote an inflammatory microenvironment 
characteristic in neurodegenerative diseases. Consistent with the role of astrocytes in mediating 
immunological homeostasis through its interactions with other cell types, the ER stress-induced 
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upregulation in astrocytic inflammatory processes can encourage an inflammatory M1-like 
phenotype in microglia [77]. Similarly, neuronal ER stress has been shown to be positively 
correlated with microglial activation in a traumatic brain injury rat model [199]. ER stress not only 
influences pathways that result in the production of inflammatory mediators, but it also alters the 
responsiveness of cells to immunogenic stimuli. To this point, it has been documented that the 
administration of both prostaglandin E2 and IFN-γ synergizes with ER stress to increase the 
production of IL-6 in glial cells [200]. Likewise, TNF-α autocrine signaling during ER stress 
significantly enhances the apoptotic signals of the UPR [201]. 
PERK knockdown experiments suggest that the association between ER stressed astrocytes 
and microglia activation is initially dependent on PERK signaling in astrocytes [77]. PERK 
haploinsufficiency and partial PERK inhibition using the small molecule PERK inhibitor 
GSK2606414 selectively attenuates the production of ER stress-induced inflammatory cytokines 
and chemokines, including IL-6, C-C Motif Chemokine Ligand (CCL)2 and CCL20 [202]. 
Interestingly, treating ER stressed astrocytes with ISRIB, a compound which reverses the 
translational block of phosphorylated eIF2α, attenuates ER stress-induced inflammatory gene 
expression [202]. We propose that the inflammatory signals induced during ER stress in astrocytes 
significantly relies on PERK-dependent eIF2α phosphorylation. These beneficial outcomes of 
PERK-eIF2α modulation fall in line with previous studies demonstrating that treating prion-
diseased mice with GSK2606414 or ISRIB confers neuroprotection by partially recovering global 
translation rates [203, 204]. Conversely, preventing eIF2α de-phosphorylation in response to 
tramatic brain injury using salubrinal is beneficial and attenuates neuroinflammation [205]. While 
it is becoming clear that PERK signaling has an important role in the regulation of 
neuroinflammation and neurodegeneration, a more complete understanding of the PERK-eIF2α 
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pathway is needed to define the context and cell-specific roles. Therefore, manipulating the PERK-
eIF2α axis without disturbing its homeostatic function could present an unappreciated way to 
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Chapter 3: Methodology 
 
3.1. Reagents 
TaqMan primers were purchased from Life Technologies. Ac-DEVD-AMC (N-Acetyl-
Asp-Glu-Val-Asp-7-amido-4-Methylcoumarin) was purchased from BD Biociences. Antibody 
(Ab) for XBP1 was from Abcam. Ab for GAPDH was from EMD Millipore Corp. Abs for JNK 
and P-JNK were from Cell Signaling Technology. Abs for ATF4, CHOP and GRP78 were from 
Santa Cruz Biotechnology, Inc. Thapsigargin (Thaps) and tunicamycin were from Calbiochem. 
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), HEPES, nonessential 
amino acids, L-glutamine, and penicillin-streptomycin were from Cellgro. Nonessential amino 
acids and gentamicin were from Lonza. Proteinase K was purchased from Promega. The Pierce 
Lactate Dehydrogenase (LDH) Cytoxicity Assay Kit was purchased from ThermoFisher 
Scientific. The terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay was 
purchased from Trevige. B-27 serum-free supplement (50X) liquid was obtained from 
ThermoFisher Scientific. 
3.2. Mice and Primary Cell Preparations 
C57BL/6 mice were bred and housed in the animal facility at West Virginia University 
under the care of the animal resources program. Primary murine astrocyte cultures were prepared 
as previously described [7]. Astrocytes were cultured in DMEM with 10% FBS, 16 mM HEPES, 
1 x nonessential amino acids, 2 mM L-glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, 




3.3. Conditioned Media 
Primary murine astrocyte cultures were treated with 1.0 µM Thaps for 2 h. Cells were 
washed with Dulbecco’s phosphate-buffered saline (PBS), and then incubated in fresh DMEM 
media for 24 h. Conditioned media was centrifuged at 1,600 rpm for 10 min to pellet cellular 
debris. Media was collected and used for conditioned media experiments. Untreated cells 
concomitantly underwent the procedure. The vehicle (control) was treated with DMSO. 
3.4. Immunoblotting Analysis 
Cells were washed twice with PBS and lysed with immunoprecipitation (IP) lysis buffer 
(20 mM Tris [pH 7.5], 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 0.5% NP-40, and 1 x 
phosphatase/protease inhibitor cocktail [Pierce, Rockford, IL]). Protein concentrations were 
determined using the bicinchonicic acid assay (BCA) assay (Pierce, Rockford, IL). Equal amounts 
of protein from each sample were solubilized in Laemmli sample buffer (2% SDS) and heated for 
5 min at 95°C. Proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred 
to nitrocellulose, and the membranes were blocked in 5% milk followed by an overnight incubation 
at 4°C with primary Ab diluted in 5% bovine serum albumin (BSA) or milk, according to the 
manufacturer’s recommendation. Horseradish peroxidase-conjugated donkey anti-rabbit or 
donkey anti-mouse (1:2,000 dilution) secondary Ab was incubated for 1 h at room temperature, 
followed by detection with enhanced chemiluminescence.  
3.5. Reverse Transcription-quantitative Polymerase Chain Reaction (qRT-PCR) 
RNA was isolated using TRIzol (Fisher). RNA was quantified using a NanoDrop system 
(Fisher). One microgram of RNA was used for cDNA synthesis using Moloney murine leukemia 
virus (MMLV) reverse transcriptase (Promega). The cDNA was analyzed by quantitative PCR 
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performed using TaqMan gene expression assays using Agilent Stratagene Mx3005P software. 
Reactions were carried out in 20 µl and analyzed using the threshold cycle (∆∆CT) method. 
3.6. Determining Cell Viability 
3.6.1. Caspase-3 Activity Assay 
Cleaved caspase-3 assay was carried out according to the manufacturer’s instructions using 
the caspase-3 substrate Ac-DEVD-AMC. Briefly, cells were incubated with 200 µL of buffer [final 
concentrations in 3x buffer: 150 mM HEPES, 450 mM NaCl, 150 mM KCl, 30 mM MgCl2, 1.5% 
NP-40 alternative, 1.2 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid 
(EGTA), 0.03% 3-[(3-cholamidopropyl)dimethylammonio-1-propanessulonate (CHAPS), and 
30% sucrose, 1.5 mM of the fluorogenic substrate Ac-DEVD-AMC, 1 M Dithiothreitol (DTT) and 
100 mM Phenylmethysulfonyl (PMSF)] following treatment. After incubation at 37oC for 1 h, the 
release of AMC was measured with excitation at 360 nm and emission at 460 nm using 
fluorescence spectrophotometry. 
3.6.2. LDH Assay 
The LDH assay was carried out according to the manufacturer’s instructions and as 
describe previously [2]. In brief, 50 µL supernatant from cells treated with the indicated 
compounds/conditioned media and 50 uL of reaction mixture (Substrate mix and Assay Buffer) 
was transferred to one well in a 96-well plate. Following incubation at room temperature for 30 
min, 50 uL stop solution was added to each well. Extracellular LDH in the media was quantified 
by measuring the absorbance of released formazan dye at 490 nm with a subtraction wavelength 
of 680 nm. Relative LDH activity was calculated using the following equation: 
Treatment LDH activity (UT/Treatment) / maximal LDH activity (UT/Treatment) 
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3.6.3 TUNEL Assay 
The TUNEL assay was carried out on cells in monolayer using the protocol provided by 
the TACS® 2 TdT Fluorescein kit (Trevige). In brief, cells were fixed on coverslips using 4% 
paraformaldehyde following the indicated treatment. After treatment with Proteinase K solution, 
the sample was immersed in Labeling Reaction Mix for 1 h in a humidified chamber. The reaction 
was halted by immersing samples with 1X TdT Stop Buffer at room temperature. Samples were 
covered with Strep-Fluor solution for 20 min in the dark, then viewed under a fluorescence 
microscope. TUNEL positive cells were counted. DAPI was used to label nuclei.  
3.7. Microparticle Isolation by Ultracentrifugation 
Conditioned media was collected from cells and centrifuged at 1,600 x g at 4oC for 5 
minutes to remove cellular debris. The centrifuged conditioned media was collected separately 
from the pellet and used for ultracentrifugation. Samples were spun at 160,000 x g at 4oC for 1 h 
using Nalgene Oak Ridge conical tubes (Thermo Fisher Scientific). Conditioned media was 
collected and the pellet was reconstituted in Dulbecco’s PBS. Both the ultracentrifuged media and 
microparticale-containing solution was used for the conditioned media experiments. 
3.8. Treatment of Conditioned Media with Proteinase K 
 Proteinase K (Promega), which contained proteinase K enzyme covalently attached to 
agarose beads, was used to digest protein molecules within the conditioned media. In brief, a 1.5 
mL tube containing 1 mL B-27 supplemented media serum-free conditioned media and 100 µL 
proteinase K slurry (proteinase K + PBS) incubated in a 37oC thermocycler at 500 rpm for 1 h. 
Samples were then centrifuged at 2,000 x g for 2 min to pellet the agarose, and thus the proteinase 
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K enzyme. The proteinase K-treated conditioned media was incubated with the indicated receiver 
cells to determine if the ER stress-inducing stress factor was a protein. 
3.9. Statistical Analysis 
 Statistical differences between experimental groups were determined using the software 
program GraphPad Prism. One-way ANOVA was used to determine statistically significant 
differences between the means of three or more independent groups. Two-way ANOVA was used 
to determine statistically significant differences between groups with more than one independent 
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Chapter 4: Results 
 
4.1. ER stress is Transmissible among Cells of the CNS in vitro. 
We recently demonstrated that ER stressed astrocytes can upregulate inflammatory gene 
expression in microglia [1]. Because it has been shown that transmissible ER stress maybe a 
relevant phenomenon in cancer [2], we investigated whether ER stress generated in astrocytes 
could trigger the secretion of molecules which, in turn, regulate ER stress responses in unstressed 
CNS cells. To do this, we produced, then transferred ER stressed ACM to unstressed astrocytes 
and neurons. As described in Figure 1A, astrocytes were stimulated with the ER stress-inducing 
agent Thaps, a non-competitive inhibitor of the sarco/endoplasmic 
reticulum Ca2+ ATPase (SERCA) [3], for 2 h to induce transient ER stress. The ability of Thaps to 
induce ER stress in astrocytes has been shown in previous studies [1, 4]. We followed the treatment 
with a 24 h wash out period with fresh media. This step is critical as any mediator secreted from 
ER stressed astrocytes would be collected in the media without the presence of Thaps. Therefore, 
we could determine whether ER stressed astrocytes could modulate ER stress responses in 
unstressed cells through a paracrine mechanism by incubating different receiver cells with the 
conditioned media. No difference in lactate dehydrogenase (LDH) activity was detected in the 
conditioned media, indicating that the secretory profile of the astrocytes during the washout period 
was not a product of cell death (Figure 1A). This finding is consistent with our previous 
observations that astrocyte viability was not compromised when stimulated with various 
concentrations of Thaps for 24 h [1]. Importantly, a previous study using an identical procedure 
detected no carry over Thaps when analyzing the conditioned media of ER stressed cells using 
mass spectroscopy [2]. 
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To determine if ER stress could initiate the secretion of ER stress-inducing molecules from 
astrocytes, we incubated primary murine astrocytes and the murine HT-22 neuronal cell line with 
ER stressed ACM for 6 h. The contents within the ER stressed ACM significantly upregulated the 
expression of downstream signaling components associated with all three arms of the UPR relative 
to cells incubated with control ACM (Figure 1B-C). We performed a similar experiment using 
ER stressed ACM derived from astrocytes stimulated with tunicamycin (Tunic), an N-
glycosylation inhibitor. The use of another ER stress-inducing agent was important because it 
would show that ER stress transmission could be initiated by multiple insults which promote ER 
stress. Similar to our findings using Thaps, ER stressed ACM from Tunic-treated astrocytes 
increased ATF4, CHOP and GRP78 protein expression in HT-22 neurons, albeit after 18 h (Figure 
1D). Based on our previous observations, treating astrocytes with Tunic for >2 h does not reduce 
cell viability [1]. It appears that ER stressed ACM from Tunic-treated astrocytes is not as potent 
as media from Thaps-treated astrocytes, possibly due to the differential mechanism of action 
between the two pharmacological agents. 
Consistent with our previous findings that ER stressed astrocytes promote inflammatory signaling 
in microglia without the need for cell-to-cell contact [1], we show that ER stressed ACM induces 
the expression of IL-6, CCL2 and CCL20 mRNA in other astrocytes (Figure 2). Pretreating 
receiver astrocytes with TUDCA, a chemical chaperone known to alleviate ER stress, partly 
reduces the transcription of genes encoding these signaling proteins (Figure 2). This finding 
implies that ER stressed astrocytes are secreting mediators which promote ER stress-dependent 
and -independent inflammatory signaling in receiver astrocytes.  
4.2. ER Stressed Astrocytes initially Protect Neurons against Subsequent Stress 
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In addition to mediating inflammatory and ER stress responses, we wanted to determine whether 
ER stressed astrocytes were able to confer stress resistance to neurons. HT-22 neurons exposed to 
ER stressed ACM for 24 h succumb to apoptosis (Figure 3A-C). No differences in caspase-3 
activity were observed between the groups incubated with ER stressed ACM relative to the control 
after 6 h, indicating that the factor(s) within the ACM became cytotoxic to neurons after 6 h 
(Figure 3A). Next, we sought to identify the conditions necessary for ER stressed ACM to induce 
a hormetic response in neurons. We chose to follow the accepted model proposing that the low-
level activation of the ER stress sensors promotes an adaptive state by selectively upregulating the 
expression of pro-survival proteins, without the concomitant expression of UPR-associated 
apoptotic factors [5]. To this point, we set our preconditioning standards where neurons highly 
expressed chaperone proteins (GRP78, pro-survival [6]) and do not express CHOP, which is 
considered apoptotic [7-9].  
As shown in Figure 1C and 3C, stimulating HT-22 neurons with ER stressed ACM for 6 h 
increases the protein expression of GRP78 and CHOP. Following a 24 h washout period, GRP78 
protein expression was maintained, while CHOP protein expression dissipated, consistent with the 
short half-life of CHOP [10] (Figure 3D). Although stimulating neurons for 2 h with ER stressed 
ACM, followed with a 4 h washout period achieves a preconditioned state, the expression of 
GRP78 is significantly reduced after 24 h (Figure 3D). This would suggest that the adapted state 
induced under these conditions is not as established compared to when neurons are stimulated for 
6 h, then allowed to recover for 24 h. Therefore, we used these conditions to determine whether 
preconditioning neurons promotes resistance against ER stress-induced cell death. 
We stimulated preconditioned neurons with Thaps for the indicated time points and analyzed the 
protein expression of phosphorylated JNK (P-JNK) and CHOP, pro-apoptotic factors induced 
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during UPR-mediated apoptosis [11] (Figure 4A-B). Additionally, we assessed caspase-3 activity 
in preconditioned neurons after Thaps treatment (Figure 4C). Pretreating neurons with ER stressed 
ACM attenuates total P-JNK, both basally and when neurons were stimulated with Thaps for 4 h 
(Figure 4A). Furthermore, we found that neurons preconditioned with ER stressed ACM exhibit 
less caspase-3 activity after a 4 treatment with Thaps (Figure 4C). This preconditioning effect 
diminished when neurons were stimulated with Thaps for 18 h, as ER stressed ACM-conditioned 
neurons had a similar expression of both CHOP and P-JNK relative to the controls (Figure 4B). 
Moreover, basal GRP78 levels were significantly reduced after 18 h, indicating that the 
preconditioned state was not maintained 42 h (24 h + 18 h) after being exposed to ER stressed 
ACM (Figure 4B). Interestingly, caspase-3 activity was still reduced in neurons preconditioned 
with ER stressed ACM after being stimulated with Thaps for 18 h (Figure 4C). We expect that 
caspase-3 activity in the preconditioned group would be closer to control levels if we had extended 
the Thaps treatment beyond 18 h. Taken together, these data indicate that ER stressed astrocytes 
initially confer stress resistance to neurons by engaging the adaptive mechanisms of the UPR to 
promote hormesis. Nevertheless, this protective effect is lost after prolonged cell-nonautonomous 
ER stress. 
4.3. The Secreted Stress Factor(s) is not a Microparticle, and Resistant to Proteinase K 
 Finally, we wanted to characterize the molecular determinant(s) secreted from ER stressed 
astrocytes that evoked ER stress responses in receiver cells. To exclude the possibility that the 
inflammatory cytokines secreted by activated astrocytes were responsible for inducing ER stress 
in neurons, we stimulated neurons with IL-6 for 6 h (Figure 5A). IL-6 is major pro-inflammatory 
cytokine secreted by ER stressed astrocytes [4], and it is well known that IL-6-driven inflammatory 
responses contribute to disease-associated inflammation [12]. In addition to IL-6, we also 
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stimulated neurons with IL-1β and TNFα, both of which are considered main effectors in the 
development of pathological neuroinflammation (Figure 5A) [13, 14]. Contrary to previous 
findings with hepatocytes [15], IL-6, IL-1β or TNFα did not induce ER stress in neurons after 6 h 
in vitro, even when using a physiologically high concentration (10 ng/mL) (Figure 5A). This 
finding supports a previous observation where transmissible ER stress between tumor cells and 
macrophages did not involve the IL-6 receptor [2]. Moreover, toll-like receptor 2 and 4 also appear 
to be indispensable in this phenomenon [2, 16].  
Extracellular vesicle secretion provides a means of transcellular communication in the CNS and is 
essential for the interactive exchanges of cargo that maintain neuronal competency [17]. Under 
conditions of neurodegeneration, however, toxic substrates can potentially be incorporated into 
extracellular vesicles and perturb CNS homeostasis [18]. To determine whether microparticles 
(MP) were responsible for inducing ER stress in receiver cells, we isolated MPs from the ER 
stressed ACM using ultracentrifugation. Unstressed astrocytes incubated with MP-free ER 
stressed ACM showed a similar magnitude of induction in the transcription of ATF4, CHOP and 
GRP78 mRNA compared to astrocytes incubated with ER stressed ACM (Figure 5B). In contrast, 
astrocytes stimulated with the MP-containing solution did not show any signs of UPR activation 
(Figure 5B). These findings indicated that the extracellular vesicles in the conditioned media were 
not the stress factor(s) responsible for inducing ER stress in astrocytes or neurons. 
Next, we pretreated ER stressed ACM with proteinase K to digest the protein molecules within the 
sample. If the ACM failed to induce ER stress in receiver cells following proteinase K treatment, 
this would indicate that the secreted stress factor(s) is a protein. We show that proteinase K-treated 
ER stressed ACM still induces CHOP and GRP78 gene transcription, suggesting that the stress 
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factor(s) responsible for inducing cell-nonautonomous UPR activation is not resistant to proteinase 





















4.4. Figure Legend 
Figure 1. ER stressed astrocytes secrete molecules which upregulate ER stress responses in 
multiple receiver cell types. (A) Outline for the astrocyte conditioned media (ACM) experiments. 
Following treatment with the vehicle (DMSO) or 1.0 µM thapsigargin (Thaps) for 2 h, primary 
murine astrocyte cultures were washed with PBS three times, then allowed to incubate in fresh 
media for 24 h. After this period, the media (ACM) was collected. Lactate dehydrogenase (LDH) 
activity in the collected ACM was measured using the LDH assay. (B-C) Primary murine 
astrocytes (B) and murine HT-22 hippocampal neurons (C) incubated with control (UT ACM) or 
ER stressed ACM (Thaps ACM) for 6 h. CHOP and GRP78 mRNA expression was quantified 
using RT-qPCR. Immunoblot analysis was used to examine GRP78, spliced XBP-1 (sXBP-1) and 
CHOP protein expression. 1.0 µM (B) or 0.1 µM (C) Thaps was used as the positive control for B 
and C, respectively. GAPDH was used as the loading control. (D) HT-22 neurons incubated with 
control or ER stressed ACM from tunicamycin (Tunic)-treated primary murine astrocytes for the 
indicated time points. Immunoblot analysis was used to examine GRP78, ATF4 and CHOP protein 
expression. GAPDH was used as the loading control. All values are mean ± SE. n.s., not significant 
P > 0.05; *, P ≤ 0.05; **, P ≤ 0.001; ***, P ≤ 0.0001; ****, P ≤ 0.00001. 
 
Figure 2. Cell-nonautonomous ER stress promotes inflammatory signaling in astrocytes. 
Astrocytes were pretreated with the chemical chaperone TUDCA (500 µM) for 24 h prior to 
incubating with control or ER stressed astrocyte conditioned media (UT or Thaps ACM) for 6 h. 
IL-6, CCL2 and CCL20 mRNA expression was quantified using RT-qPCR. All values are mean ± 




Figure 3. Mild exposure to stress factors promotes an adaptive state in neurons. (A) Murine 
HT-22 hippocampal neurons were stimulated with control or ER stressed astrocyte conditioned 
media (UT or Thaps ACM) for 6 or 24 h. Caspase-3 activity was assessed by measuring the 
fluorescence intensity of the cleaved capase-3 substrate Ac-DEVD-AMC. Caspase-3 activity was 
expressed as arbitrary fluorescence units. (B) Immunoblot analysis was used to examine cleaved 
caspase-3 and caspase-3 protein expression in HT-22 neurons stimulated with control or ER 
stressed conditioned media for the indicated time points. (C) The TUNEL assay was utilized to 
label 3’-OH termini of double-stranded DNA breaks in neurons treated with control (UTA) or ER 
stressed ACM (TA) for 24 h. Strand breaks were visualized using fluorescence microscopy. (D) 
HT-22 neurons incubated with 25% control or ER stressed ACM for the indicated time points. 
GRP78 and CHOP protein expression was examined using immunoblot analysis. (E) HT-22 
neurons incubated with 25% control or ER stressed ACM for 2 or 6 h, followed with a 4 or 24 h 
washout period. GRP78 and CHOP protein expression was examined using immunoblot analysis. 
GAPDH was used as the loading control (D-E). UT, untreated; UTA, control ACM; TA, Thaps 
ACM. All values are mean ± SE. n.s., not significant P > 0.05; *, P ≤ 0.05; **, P ≤ 0.001; ***, P 
≤ 0.0001; ****, P ≤ 0.00001. 
 
Figure 4. Conditioned media from ER stressed astrocytes confer stress resistance to neurons. 
Murine HT-22 hippocampal neurons were preconditioned with 25% control (UTA or UT ACM) or 
ER stressed ACM (TA or Thaps ACM) for 6 h, followed by a 24 h recovery period with fresh 
media. (A-B) GRP78, phosphorylated JNK (P-JNK) and CHOP protein expression was assessed 
using immunoblot analysis. GAPDH was used as the loading control. Data are a representation of 
three independent experiments. (C) Caspase-3 activity was analyzed by measuring the 
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fluorescence intensity of the cleaved caspase-3 substrate Ac-DEVD-AMC after preconditioned 
HT-22 neurons were stimulated with either the vehicle (DMSO) or 0.1 µM thapsigargin (Thaps) 
for 4 h or 18 h. Caspase-3 activity was expressed as arbitrary fluorescence units. All values are 
mean ± SE. n.s., not significant P > 0.05; *, P ≤ 0.05; **, P ≤ 0.001; ***, P ≤ 0.0001; ****, P ≤ 
0.00001. 
 
Figure 5. The stress factor(s) secreted by ER stressed astrocytes is not microparticle, and is 
resistant to proteinase K. (A) Murine HT-22 hippocampal neurons were stimulated with 10 
ng/mL of IL-1β, IL-6 or TNFα for 6 h.  CHOP and GRP78 mRNA expression was quantified using 
RT-qPCR. Thaps (1µM) was used as a positive control. (B) Microparticles (MP) were isolated 
from the ER stressed astrocyte conditioned media (ACM) via ultracentrifugation (160,000 x g for 
1 h). The MP-free ACM remaining after high-speed centrifugation was collected, and the pellet at 
the bottom of the tube (contains MPs) was resuspended in PBS. The centrifuged ACM 
(thapsigargin (Thaps) ACM No MP) and the solution containing the MPs (Thaps ACM MP) 
incubated with astrocytes for 6 h. ATF4, CHOP and GRP78 mRNA was quantified using RT-qPCR. 
(C) ER stressed ACM was treated with proteinase K bound by agarose beads for 1 h at 37
o
C. After 
which, the ACM was centrifuged at 1000 x g for 2 min to separate the beads and the media. The 
proteinase K-free ACM was collected, then allowed to incubate with astrocytes for 4 h. CHOP and 
GRP78 mRNA was quantified using RT-qPCR. To confirm that proteinase K was functional, 1 
mg/mL of BSA was treated with proteinase K for 1 h at 37
o
C. Proteins from the BSA (lanes 1 and 
2) or proteinase K-treated BSA (lanes 3 and 4) solutions were stained using Coomassie Blue 
staining following SDS-PAGE. All values are mean ± SE. n.s., not significant P > 0.05; *, P ≤ 
0.05; **, P ≤ 0.001; ***, P ≤ 0.0001; ****, P ≤ 0.00001. 
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Figure 6. Schematic representing the cell-nonautonomous influence of ER stressed astrocytes 

















































1. Meares GP, Liu Y, Rajbhandari R, Qin H, Nozell SE, Mobley JA, Corbett JA, Benveniste 
EN: PERK-Dependent Activation of JAK1 and STAT3 Contributes to Endoplasmic 
Reticulum Stress-Induced Inflammation. Mol Cell Biol 2014, 34(20):3911-3925. 
2. Mahadevan NR, Rodvold J, Sepulveda H, Rossi S, Drew AF, Zanetti M: Transmission 
of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid 
cells. Proc Natl Acad Sci U S A 2011, 108(16):6561-6566. 
3. Lytton J, Westlin M, Hanley MR: Thapsigargin inhibits the sarcoplasmic or 
endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 1991, 
266(26):17067-17071. 
4. Guthrie LN, Abiraman K, Plyler ES, Sprenkle NT, Gibson SA, McFarland BC, 
Rajbhandari R, Rowse AL, Benveniste EN, Meares GP: Attenuation of PKR-like ER 
Kinase (PERK) Signaling Selectively Controls Endoplasmic Reticulum Stress-
induced Inflammation Without Compromising Immunological Responses. J Biol 
Chem 2016, 291(30):15830-15840. 
5. Rutkowski D, Arnold S, Miller C, Wu J, Li J, Gunnison K, Mori K, Sadighi Akha A, 
Raden D, Kaufman R: Adaptation to ER stress is mediated by differential stabilities 
of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 2006, 4(11):e374. 
6. Racek T, Buhlmann S, Rust F, Knoll S, Alla V, Putzer BM: Transcriptional repression 
of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1. J Biol 
Chem 2008, 283(49):34305-34314. 
7. Li Y, Guo Y, Tang J, Jiang J, Chen Z: New insights into the roles of CHOP-induced 
apoptosis in ER stress. Acta Biochim Biophys Sinica 2014, 46(8):629-640. 
8. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding 
HP, Ron D: CHOP induces death by promoting protein synthesis and oxidation in 
the stressed endoplasmic reticulum. Genes Dev 2004, 18(24):3066-3077. 
9. Song B, Scheuner D, Ron D, Pennathur S, Kaufman RJ: Chop deletion reduces 
oxidative stress, improves beta cell function, and promotes cell survival in multiple 
mouse models of diabetes. J Clin Invest  2008, 118(10):3378-3389. 
10. Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM, Mori K, Sadighi Akha 
AA, Raden D, Kaufman RJ: Adaptation to ER stress is mediated by differential 
stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 2006, 
4(11):e374. 
11. Tabas I, Ron D: Integrating the mechanisms of apoptosis induced by endoplasmic 
reticulum stress. Nat Cell Biol 2011, 13(3):184-190. 
12. Gabay C: Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006, 8 Suppl 
2:S3. 
13. Leal MC, Casabona JC, Puntel M, Pitossi FJ: Interleukin-1beta and tumor necrosis 
factor-alpha: reliable targets for protective therapies in Parkinson's Disease? Front 
Cell Neurosci 2013, 7:53. 
14. Yuan L, Neufeld AH: Tumor necrosis factor-alpha: a potentially neurodestructive 




15. Zhang K, Shen X, Wu J, Sakaki K, Saunders T, Rutkowski DT, Back SH, Kaufman RJ: 
Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic 
inflammatory response. Cell 2006, 124(3):587-599. 
16. Zhang H, Yue Y, Sun T, Wu X, Xiong S: Transmissible endoplasmic reticulum stress 
from myocardiocytes to macrophages is pivotal for the pathogenesis of CVB3-
induced viral myocarditis. Sci Rep 2017, 7:42162. 
17. Budnik V, Ruiz-Cañada C, Wendler F: Extracellular vesicles round off 
communication in the nervous system. Nat Rev Neurosci 2016, 17(3):160-172. 
18. Thompson AG, Gray E, Heman-Ackah SM, Mäger I, Talbot K, Andaloussi SE, Wood 
MJ, Turner MR: Extracellular vesicles in neurodegenerative disease - pathogenesis to 




Chapter 5: Discussion 
 
5.1. Discussion 
Studies investigating how pathological UPR signaling contributes to neurodegenerative diseases 
have largely focused on neuronal cell-autonomous mechanisms. Nevertheless, there still remains 
a plethora of questions regarding the cell-nonautonomous role of the UPR under normal 
physiology, and how this mechanism is compromised in diseased states. To our knowledge, we 
provide the first evidence showing that ER stress is transmissible among mammalian CNS cells. 
The activation of the UPR has been shown to play an essential role in maintaining vital biological 
processes within the brain during cellular stress. In fact, moderate ER stress enhances cellular 
protection against subsequent ER stress-inducing stimuli by improving the adaptive capacity of 
the cell, a response called the hormetic response [1]. These observations led us to the thinking that 
transmissible ER stress could be essential for alerting surrounding cells about upcoming distresses, 
and to prepare them for subsequent insult by initiating the adaptive signals of the UPR.   In support 
of this concept, direct activation of sXBP-1, a downstream transcription factor of the IRE-1α 
pathway, in neurons has been shown to improve stress resistance in distal, non-neuronal cells by 
regulating UPR signaling components through the secretion of neurotransmitters in 
Caenorhabditis elegans [2].  In agreement with these findings, our data suggest that ER stressed 
astrocytes initially protect neurons by inducing mild, cell-nonautonomous ER stress, which in turn 
increases their resistance against sequential ER stress (Figure 4).    
It is important to note that the cell-nonautonomous effects induced by Thaps may not necessarily 
be due to ER stress. To this point, Thaps administration significantly elevates the concentration of 
cytosolic calcium by impairing the transport of once ER-localized calcium back into the ER lumen 
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[3]. High levels of cytosolic calcium, in turn, affects a number of biological processes. For 
example, high cytosolic concentrations of calcium can stimulate inflammatory gene expression [4] 
and facilitate mitochondrial damage [5, 6]. We must stress that decreases in ER calcium levels are 
not specific to Thaps treatment, but rather it is a common event that contributes to ER dysfunction 
[7] and is a consequence of abnormal UPR signaling [5, 8, 9]. In addition, alterations in the redox 
environment resulting from the enhanced generation of reactive oxygen species (ROS) during ER 
stress may profoundly disrupt many normal cellular activities [10]. Since perturbations in ER 
homeostasis affects a number of processes involved in cellular physiology, it should be considered 
that disturbances in other aspects of cell biology caused by the ER stress response may promote 
the secretion of this unknown molecule(s). Further, the use of Tunic, an inhibitor of N-
acetylglucosamine phosphotransferase that abrogates N-glycoslyation, was essential in supporting 
that our results using Thaps as an ER stress-inducing agent was not simply a product of any of its 
off-target effects (Figure 1D). 
A number of CNS-resident cells, including astrocytes, microglia and neurons, secrete membrane-
bound nanovesicles called exosomes under normal and pathological conditions [11]. In a study 
evaluating prion diseases, abnormally folded prion aggregates were found to associate with 
neuronal exosomes and infect both neuronal and non-neuronal cells without the need for direct 
cell-to-cell contact [12]. It was tempting to speculate that the factor(s) secreted from ER stressed 
cells were extracellular vesicles containing a heterogeneous species of RNA, protein or lipid that 
could induce ER stress in unstressed cell types. However, our MP isolation experiments 
demonstrated that both exosomes and other microvescles secreted by ER stressed astrocytes do 
not upregulate UPR markers in recipient astrocytes (Figure 5A). In parallel, it doesn’t seem that 
MPs secreted from cancer cells are responsible for triggering both ER stress and proinflammatory 
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responses in receiver myeloid cells [13]. Treating ER stressed ACM with proteinase K did not 
rescue receiver cells from ER stress, suggesting that the stress molecule(s) is not a protein. 
However, we cannot exclude the possibility that it may exist in a proteinase K-resistant form, as 
disease-associated prion proteins do [14]. To add to the characterization of this stress factor(s), it 
appears that it cannot be inactivated by heat [15]. 
Identifying the soluble stress molecule(s) secreted by ER stressed astrocytes will be essential in 
order to better understand the molecular mechanisms involved in the cell-extrinsic regulatory 
function of the UPR. Based on our findings, transmissible ER stress does not appear to require 
cell-to-cell contact, thus supporting the notion that ER stress transmission is mediated by a stress-
induced soluble molecule(s) [16]. While ER stress in other cell types has been shown to trigger 
the secretion of ER stress-inducing molecules, the identity of this factor(s) still remains elusive 
[13, 15, 16]. It is important to consider that this mediator(s) may not be a conventional DAMP, but 
rather an intracellular constituents released from the cell in an effort to alleviate ER stress. The 
secretion of products from the cell could be the result of an autophagy-dependent unconventional 
secretion pathway that is induced during cellular stress. The UPR is a well-known trigger of 
autophagosome formation, and the secretion of alarmins through this non-canonical autophagy 
pathway has been shown to serve different extracellular functions [17, 18]. These secretory 
byproducts may, in turn, promote ER stress in neighboring cells. Nevertheless, this is purely 
speculation.  
5.2. Overall Conclusions 
To summarize, other studies investigating transmissible ER stress between mammalian cells 
discuss its potential role in disease progression. As represented in Figure 6, we propose that ER 
stressed astrocytes are able to confer resistance against upcoming ER stress-inducing insults to 
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neurons by promoting the low-level activation of the UPR. In doing so, the pro-survival signals 
associated with the ER stress response are engaged (i.e. increased expression of molecular 
chaperones), thus enhancing the protein folding capacity of the cell. Nevertheless, chronic 
exposure to the uncharacterized stress factor(s) secreted by activated astrocytes induces 
unresolvable ER stress, which favors the initiation of UPR-dependent apoptosis. Therefore, the 
release of both inflammatory mediators (i.e. cytokines and ROS) and the ER stress-inducing 
factor(s) by dysfunctional astrocytes could contribute to the cell-nonautonomous mechanisms that 
drive the neurotoxic events observed in many neurodegenerative disorders. 
These findings provide insight into the cell-extrinsic influence of the UPR on cells of the CNS. 
Because persistent ER stress generated during neuropathology turns the UPR into a pathological 
factor, understanding the molecular mechanisms underlying the cell-extrinsic functions of the UPR 
would present novel therapeutic opportunities to treat neurodegenerative diseases. 
5.3. Future Direction 
We hope to examine the relevance of our in vitro findings in a murine in vivo model. Currently, 
we are collaborating with Dr. Brain Popko and his laboratory at the University of Chicago to 
elucidate whether ER stress is transmissible within the CNS. We are taking advantage of the Jimpy 
mouse model to understand if ER stressed oligodendrocytes transmit ER stress to other cell types. 
Jimpy mice possess a mutation in the gene encoding the transmembrane protein proteolipid protein 
(PLP) that makes the protein susceptible to misfolding, thus leading to ER stress. 
Immunohistochemistry will enable us to visualize whether ER stress is being generated in non-
oligodendrocyte cell types (i.e. astrocytes, microglia, and neurons).  
5.4. Potential Problems and their Solution 
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PLP is vital for maintaining the structural integrity of the myelin sheath that insulates neuronal 
axons in the CNS. By mutating this protein we may compromise neuronal function if PLP is not 
properly expressed, which may lead to confounding results. Nevertheless, Klugmann et al. 
purposed that myelin produced by murine PLP-null oligodendrocytes is capable of being stably 
compacted around axons for >1 y, and that the disease phenotype associated with jimpy mice is 
dependent on the toxic effects of misfolded PLP on oligodendrocytes [19]. Therefore, analysis of 
jimpy mice must be carried out before it is expected that the myelin architecture becomes unstable 
(<1 y postnatal). To further support that ER stress generated in the oligodendrocytes can initiate 
ER stress transmission in vivo, we will attempt to recapitulate our in vitro findings using primary 
murine oligodendrocytes, if we indeed observe ER stress markers in both oligodendrocytes and 
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